Headquartered in Denver, CO Fiscal year ends December NYSE: DOC healthpeak.com
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery. The company's portfolio is organized across three primary reportable segments: Outpatient Medical (501 properties), Lab (141 properties), and Senior Housing (41 properties, operated through majority-owned subsidiary Janus Living, Inc., NYSE: JAN, in which Healthpeak holds a 73.6% equity interest). Healthpeak maintains deep relationships with major health systems, including Northside Hospital, and partners with institutional investors such as Brookfield Asset Management through joint venture structures. The company trades on the NYSE under the ticker DOC. Updated
Healthpeak's 6.48% yield looks tempting after an 8% share price drop, but this healthcare REIT has cut its dividend twice before and now faces a shrinking earnings cushion, rising interest costs, and…
America's aging population is funneling hundreds of billions into healthcare each year, and three healthcare REITs are positioning to collect a growing share of that spending through very different strategies. Which one…
Income investors entering July 2026 are getting a friendlier setup than they had six months ago. The 10-year Treasury yield sits at 4%, down from its May 19 peak of 5%, and…
The Standard & Poor’s 500 is a stock market index that tracks the performance of the 500 biggest companies in the United States. It is considered a top indicator of the U.S.…
The Invesco S&P 500 High Dividend Low Volatility ETF (NYSEARCA:SPHD) sells the most appealing pitch in income investing: take the highest yielders in the S&P 500, filter for the calmest fifty, collect…
Pre-Market Stock Futures: Futures are trading lower as we get set to start the new trading week, as reports indicate that President Trump declined Iran’s counteroffer for peace. This comes after a…
After a 35-year career in the financial industry, including two decades as an institutional stockbroker at Bear Stearns, Lehman Brothers, and Morgan Stanley, I developed an institutional perspective on dividend-focused investing. My…
High-yield dividend stocks offer cash flow with full liquidity, meaning you can add, trim, or exit a position on any trading day. That combination of yield and flexibility is why income-focused investors…
Healthcare real estate investment trusts (REITs), which own properties such as senior housing, medical office buildings, skilled nursing facilities, and hospitals, may present a compelling opportunity right now. The demographic tailwind is…
$500 per month may seem small, but it’s not a trivial amount and can snowball your portfolio quickly. Monthly dividend stocks like Realty Income (NYSE:O), Healthpeak Properties (NYSE:DOC), and Northland Power (OTCMKTS:NPIFF)…
After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional perspective on dividend stock investing. My tenure at these premier Wall Street firms exposed…
Most dividend investors seek solid passive income streams from quality dividend stocks. Passive income is a steady stream of unearned income that doesn’t require active traditional work. Shared ideas for earning passive…
The S&P 500 index includes a broad variety of companies. Some of them pay little to no dividends, while others offer decent yields. Among the S&P 500 companies that pay dividends, the…
While many Baby Boomers have enjoyed a long bull market over the past 35 years, there is a point when income becomes more critical than stock appreciation. The reason is simple: those…
The red-hot January non-farm payrolls report blew away Wall Street, and almost at once, the prediction for 2.5 rate cuts this year was slashed to 2. In addition, if the January consumer…
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery.
The Wall Street consensus 12-month price target for DOC is $22.95.
